首页> 外文OA文献 >PMH9 COST-EFFECTIVENESS OF CLINICALLY PROVEN TREATMENT STRATEGIES FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN FIVE JURISDICTIONS

【2h】

PMH9 COST-EFFECTIVENESS OF CLINICALLY PROVEN TREATMENT STRATEGIES FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN FIVE JURISDICTIONS

机译：PMH9在五个辖区的临床证明治疗策略的注意力缺陷/多动障碍（ADHD）的成本效益

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Schlander M; Schwarz O; Hakkaart-van Roijen L; Jensen PS; Persson U; Santosh PJ; Trott GE;
展开▼
作者单位

展开▼
年度 2006
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD [J] . Jean Lachaine, Vanja Sikirica, Karine Mathurin BMC Psychiatry . 2016,第1期

机译：在加拿大是否存在治疗注意力不足/多动障碍的辅助药物疗法，在成本方面是否合算：胍法辛缓释作为长效兴奋剂治疗ADHD的辅助疗法的成本效益评估
2. Pharmacotherapeutic strategies for the treatment of attention-deficit hyperactivity (ADHD) disorder with comorbid substance-use disorder (SUD) [J] . Perugi, G, Pallucchini, Expert opinion on pharmacotherapy . 2019,第1a6期

机译：用于治疗注意力缺陷多动（ADHD）紊乱的药物治疗策略（SUD）
3. Clinical Presentation, Diagnosis and Treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in Older Adults: A Review of the Evidence and its Implications for Clinical Care [J] . Goodman David W., Mitchell Sara, Rhodewalt Lauren, Drugs and aging . 2016,第1期

机译：老年人注意缺陷多动障碍（ADHD）的临床表现，诊断和治疗：证据及其对临床护理的意义的审查。
4. Social Skill Interventions on Children with Attention-Deficit Hyperactivity Disorder (ADHD): Parents and Peers Involvement [C] . Andita Faradilla ASEAN Conference on Psychology, Counselling, and Humanities . 2020

机译：关注缺陷多动障碍儿童的社会技能干预措施（ADHD）：父母和同龄人参与
5. The Lived Experience of Adults Receiving Treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). [D] . Harrison, Denise Elizabeth. 2017

机译：成人因注意力缺乏/多动症（ADHD）接受治疗的生活经验。
6. Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD [O] . Jean Lachaine, Vanja Sikirica, Karine Mathurin 2016

机译：在加拿大是否有治疗注意力不足/多动障碍的辅助药物疗法：在长效兴奋剂辅助治疗多动症时胍法辛缓释的成本效益评估
7. PMH1 COST-EFFECTIVENESS OF CLINICALLY PROVEN TREATMENT STRATEGIES FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD): IMPACT OF COEXISTING CONDITIONS [O] . Schlander M, Schwarz O, Foster EM, 2006

机译：临床上对注意力不足/多动障碍（ADHD）的治疗策略的PMH1成本效益：共存条件的影响

PMH9 COST-EFFECTIVENESS OF CLINICALLY PROVEN TREATMENT STRATEGIES FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN FIVE JURISDICTIONS

著录项

引文网络

相似文献

相关主题

期刊订阅